Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study.

Li N, Jiang Y, He S, Zhao Z, Sun J, Li M, Wang O, Xing X, Xia W.

Open source

DOI
10.1097/md.0000000000013159
Published
2018-11-01
Container
Medicine (Baltimore)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000013159,
  title = {Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study.},
  author = {Li N and  Jiang Y and  He S and  Zhao Z and  Sun J and  Li M and  Wang O and  Xing X and  Xia W.},
  year = {2018},
  journal = {Medicine (Baltimore)},
  doi = {10.1097/md.0000000000013159},
  url = {https://doi.org/10.1097/md.0000000000013159}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study.
AU  - Li N
AU  -  Jiang Y
AU  -  He S
AU  -  Zhao Z
AU  -  Sun J
AU  -  Li M
AU  -  Wang O
AU  -  Xing X
AU  -  Xia W.
PY  - 2018
JO  - Medicine (Baltimore)
DO  - 10.1097/md.0000000000013159
UR  - https://doi.org/10.1097/md.0000000000013159
ER  - 

APA

N, L., Y, J., S, H., Z, Z., J, S., M, L., O, W., X, X., & W., X. (2018). Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study.. Medicine (Baltimore). https://doi.org/10.1097/md.0000000000013159

Source records